Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Galtier-Dereure, F.
Right arrow Articles by Hédon, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galtier-Dereure, F.
Right arrow Articles by Hédon, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. 7, pp. 1393-1398, 1996
© 1996 European Society of Human Reproduction and Embryology


research-article

Endocrinology: Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: correlation with in-vitro fertilization outcome

F. Galtier-Dereure1,5, V. De Bouard2, M.C. Picot3, C. Vergnes3, C. Humeau4, J. Bringer1 and B. Hédon2

1Service d'Endocnnologie, Hôipital Lapeyrome 2Service de Gynécologie-Obstétrique, Hôpital A.de Villeneuve 3Department d'Information Médicale, Hôipital Lapeyrome 4Laboratoire de Fécondation In Vitro, Hôpital A de Villeneuve 34295 Montpellier Cedex 5, France

Correspondence: 5To whom correspondence should be addressed

A gonadotrophin-releasing hormone agonist stimulation test determination of follicle stimulating hormone (FSH) concentrations before and 2 h after buserelin injection was carried out in 78 in-vitro fertilization cycles, and compared ith basal FSH concentrations to predict ovarian response. Ovarian response was quantified by the ratio of peak oestradiol concentration divided by the total dose of human menopausal gonadotrophin (HMG) administered, the most reproducible parameter in 11 patients who underwent two treatment cycles. Stimulation outcome was highly related to the buserelin test, the best prognostic Indicator being the sum of FSH concentrations. However, basal FSH con centration achieved similar correlations, even in those patients aged >35 years. Sensitivity, specificity, positive and negative predictive values of basal FSH concentration and sum of FSH concentrations were similar. Low basal concentration and sum of FSH concentrations were both associated with a better ovarian response. Construction of receiver operating characteristic curves demonstrated that basal FSH concentration was more informative than the sum of FSH concentrations. Finally, the sum of FSH concentrations did not increase the prediction of ovarian response variability. We conclude that the buserelin test is strongly predictive of stimulation outcome, but is no more informative than the usual screening. We suggest that the performance of other stimulation tests should be clearly compared with that of basal FSH concentration.

Key words: FSH/GnRH agonistr/in-vitro fertilization/ovarian reserve/ovarian stimulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
T. Eldar-Geva, A. Ben-Chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E. J. Margalioth
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
Hum. Reprod., November 1, 2005; 20(11): 3178 - 3183.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. A. Lobo
Potential Options for Preservation of Fertility in Women
N. Engl. J. Med., July 7, 2005; 353(1): 64 - 73.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Eldar-Geva, E.J. Margalioth, A. Ben-Chetrit, M. Gal, D.M. Robertson, D.L. Healy, Y.Z. Diamant, and I.M. Spitz
Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders
Hum. Reprod., September 1, 2002; 17(9): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Pellestor, B. Andreo, F. Arnal, C. Humeau, and J. Demaille
Mechanisms of non-disjunction in human female meiosis: the co-existence of two modes of malsegregation evidenced by the karyotyping of 1397 in-vitro unfertilized oocytes
Hum. Reprod., August 1, 2002; 17(8): 2134 - 2145.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Fawzy, A. Lambert, R.F. Harrison, P.G. Knight, N. Groome, B. Hennelly, and W.R. Robertson
Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome
Hum. Reprod., June 1, 2002; 17(6): 1535 - 1543.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Nikolaou, S. Lavery, C. Turner, R. Margara, and G. Trew
Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?
Hum. Reprod., April 1, 2002; 17(4): 1106 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Lass
Assessment of ovarian reserve - is there a role for ovarian biopsy?
Hum. Reprod., June 1, 2001; 16(6): 1055 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Ravhon, S. Lavery, S. Michael, M. Donaldson, R. Margara, G. Trew, and R. Winston
Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF
Hum. Reprod., November 1, 2000; 15(11): 2297 - 2301.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, J. Balasch, F. Fabregues, F. Carmona, R. Casamitjana, V. Moreno, J. M Calafell, and J. A. Vanrell
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment
Hum. Reprod., July 1, 2000; 15(7): 1499 - 1504.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.